Abstract Topics

​​​​Within the abstract submission system, you will need to choose one of the below topics and sub-topics for ​your abstract. The sub-topic menu will automatically appear once you have selected your topic. Please take note of the following information when selecting your topic and sub-topic:

  • Sub-topics preceded by the letter “S” map to one of the plenary sessions or themed symposia of the ​Meeting. If you choose one of these sub-topics your abstract may be considered for oral presentation at the relevant symposium. 
  • Sub-topics preceded by the letters "MTP" map to one of the Meet the Professor sessions of the Meeting. Should you wish to have your abstract considered as an educational or controversial case in one of these sessions, please select the relevant sub-topic as well as the stream: Case Report or Case Series from the stream preference dropdown​​ menu. If you choose one of these topics your abstract may be considered for case presentation in one of the Meet the Professor sessions. For additional information about case submission to one of the Meet the Professor sessions, please click here​
  • Abstracts submitte​d to sub-topics preceded by the letter “G” will be selected for general oral, e-poster discussion presentation a​nd e-poster viewing.  ​
  • Each topic will indicate in brackets which types of sub-topics (S, MTP or G) are included within the category. 
  • By selecting the right topic area and stream, you will ensure your abstract fits directly into the best suited session in the programme and achieves the highest possible impact.

​List of Topics and Sub-topics: 

1.       A​​ntibiotic stewardship & infection control (S,MTP,G)

1a.  S- Antimicrobial stewardship
1b. MTP-OPAT: importance in an antibiotic stewardship programme
1c. G- Antibiotic stewardship and infection control 

2.       Antimicrobials: resistance & pharmacology (S,G)

2a. S- Antimicrobial resistance
2b. G- Antimicrobials: resistance and pharmacology  

3.       Community acquired infections: invasive bacterial (non- respiratory ) (S,MTP,G)

3a. S- Group A Streptococcus
3b. MTP- Optimal approach of meningococcal disease
3c. MTP- Severe S. aureus infections: is it a matter of resistance or toxins?
3d. G- Community acquired infections: invasive bacterial infections (non-respiratory)

4.       Respiratory (S,MTP,G)

4a. S- Prevention of pertussis in infants – the ongoing challenge
4b. MTP- Severe pertussis
4c. MTP- Bronchiolitis 
4d. MTP- ENT infections: management of complications 
4e. G- Community acquired infections: respiratory tract infections 

5.       Congenital and perinatal infections (S, MTP, G) 

5a. S- Congenital diseases
5b. S- Pregnancy and the neonate
5c. MTP- Congenital toxoplasmosis: Can we do any better?
5d. G- Congenital and perinatal infections

6.       Diagnostic tools (S,G)

6a. S- Diagnosis through host response
6b. G- Diagnostic tools

7.       Healthcare-associated and surgical infections (MTP, G)

7a. MTP- Treatment of multi-drug resistant gram negative infections 
7b. G- Healthcare-associated and surgical infections

8.   ​HIV/AIDS (S, MTP, G)

8a. S- HIV cure in children
8b. MTP- HIV in adolescents
8c. G- HIV/AIDS

9.   Host-pathogen interaction (S, G) 

9a. S- Immune dysregulation- from bed to bench and back to bed
9b. G- Host-pathogen interaction

10.   Imaging in CNS infectious diseases (MTP)

10a. MT​P- Imaging in CNS infectious diseases

11.   Infections in immunocompromised & post-transplant (S,MTP,G)

11a. S- Infections in the oncology patient 
11b. MTP- Invasive fungal infection in immunocompromised children
11c. MTP- Infections in children treated with chronic immunosuppressive therapy
11d. G- Infections in immunocompromised and transplant recipients

12.   Invasive fungal infections (MTP,G)

12a. MTP- Invasive fungal infection in immunocompromised children
12b. G- Invasive fungal infections

13.   Invasive viral infections (S,G)

13a. S- Fighting viruses
13b. G- Invasive viral infections 

14.   Non-invasive gastrointestinal and mucosal infections (MTP,G)

14a. MTP-Community acquired diarrhoea in infants
14 b. G- Non-invasive gastrointestinal and mucosal infections

15.   Public health: clinical epidemiology (G)

15a. G- Public health: clinical epidemiology

16.   Public health: molecular epidemiology and other aspects (G)

16a. G- Public ​health: molecular epidemiology and other aspects

17.   Refugee children (S)

17a. S- Refuge​e children

18.   ​Tropical/parasite infections & travel medicine (S,MTP,G)

18a. S-  Tropical viruses
18b. S-Update on Typhoid
18c. MTP- Cases in tropical infections 
18d. G- Tropical diseases, travel medicine and parasitic infections

19.   Tuberculosis and other mycobacterial infections (S, MTP, G)

19a. S-Tuberculosis in children
19b. MTP- Treatment of drug resistant TB (monoresistant, MDR, XDR) 
19c. G- Tuberculosis and other mycobacterial infections

20.   Vaccine development, immunogenicity & safety (S,G)

20a. S- From vaccine research to worldwide implementation
20b. G- Vaccine development, immunogenicity and safety
20c. G- Vaccine effectiveness and efficacy

21.   Zoonosis, vector-borne and emerging infections (MTP,G)

21a. MTP- Emerging diseases: old enemies, new challenges
21b. G- Zoonosis, vector-borne and emerging infections

22.   Other (G)

22a. G- Other


Keep Me Updated